SÜSS MicroTec SE

Quarterly Report • Nov 6, 2025

Key Figures

SUSS Group

for the period from January 1, 2025, to September 30, 2025

Earnings per share, basic (in €)* 0.48 0.68 - 1.91 4.90 -

in € million	Q3 2025	Q3 2024	Change	9M 2025	9M 2024	Change	in € million	Q3 2025	Q3 2024	Change	9M 2025	9M2024	Change
Business development							Balance sheet and cash flow
Order intake	70.0	84.0	-16.7%	236.8	276.2	-14.3%	Equity	-	-	-	304.2	261.9	+16.2%
Order book as of September 30	-	-	-	276.1	430.8	-35.9%	Equity ratio	-	-	-	58.2%	55.2%	+3.0%-Points
Sales	118.0	102.5	+15.1%	384.4	295.3	+30.2%	Balance sheet total	-	-	-	522.9	474.3	+10.2%
Gross profit	39.0	40.0	-2.5%	137.9	116.8	+18.1%	Net cash	-	-	-	43.9	122.3	-64.1%
Gross profit margin	33.1%	39.0%	-5.9%-Points	35.9%	39.6%	-3.7%-Points	Free cash flow	-0.7	+1.6	-	-28.2	+24.2	-
Cost of sales	79.0	62.4	+26.6%	246.5	178.4	+38.2%	Free cash flow total*	-3.9	+1.7	-	-31.5	+94.3	-
Research and development expenses	10.9	9.3	+17.2%	34.2	27.9	+22.6%	Further key figures
EBITDA	15.6	19.3	-19.2%	61.5	53.1	+15.8%	Capital expenditure	6.6	2.5	+164.0%	17.8	5.5	+223.6%
EBITDA margin	13.2%	18.8%	-5.6%-Points	16.0%	18.0%	-2.0%-Points	Capital expenditure ratio	5.6%	2.4%	+3.2%-Points	4.6%	1.9%	+2.7%-Points
EBIT	12.4	17.3	-28.3%	54.3	47.4	+14.6%	Depreciation	3.2	1.9	+68.4%	7.2	5.7	+26.3%
EBIT margin	10.5%	16.9%	-6.4%-Points	14.1%	16.1%	-2.0%-Points	Employees as of September 30	-	-	-	1,528	1,414	+8.1%
Earnings of continuing operations (after taxes)	9.2	12.9	-28.7%	39.8	35.4	+12.4%	* From continuing and discontinued operations
Net profit*	9.2	12.9	-	36.4	93.8	-

Content

Interim Statement as of September 30, 2025	4
Business development	4
Net assets and financial position	8
Post balance sheet date events	8
Risks and opportunities	8
Outlook	9
Financial Report (unaudited)	11
Consolidated statement of income (IFRS)	11
Statement of comprehensive income (IFRS)	12
Consolidated balance sheet (IFRS)	13
Consolidated statement of changes in equity (IFRS)	15
Consolidated statement of cash flow (IFRS)	16
Segment reporting (IFRS)	18
Earnings per share	21
Financial calendar / Contact / Imprint	22

"We cannot be satisfied with our third quarter of 2025. While we once again increased sales by 15.1% compared to the same quarter last year and are now up a healthy 30.2% on the previous year after nine months, margin pressure increased in the third quarter. Due to the double financial burden of setting up the new production site in Taiwan, lower total output compared to previous quarters, extra efforts for rework during assembly and customer ramp-up support for already installed tools, as well as an unfavorable product and customer mix, we are now significantly behind the very profitable year 2024 after nine months.

Consequently, we had to adjust our margin guidance again.

The third quarter also did not bring increased momentum in terms of order intake. However, we believe that demand is likely to pick up significantly in the fourth quarter after companies in the industry announced very specific plans to continue investing heavily in capacity for AI applications. In the coming year, we expect to see new business by the planned market launch of new system solutions, resuming our growth path and leading to a sustainable improvement in profitability from 2027 at the latest."

Interim Statement

for the period from January 1, 2025 to September 30, 2025

Business development

In the first nine months of the financial year 2025, SUSS achieved record sales, once again demonstrating improved ability to fulfill customer orders faster than in previous years. At the same time, one-time effects in the first half of the year, expenses for the startup of the new production site in Taiwan, and lower fixed cost coverage in the third quarter of 2025 due to the lower total output compared to previous quarters, weighed on profitability. Although absolute gross profit and EBIT for the year to date were higher than in the same period of the previous year, the respective margins in relation to sales were not.

Our customers' reluctance to place further orders continued in the third quarter of 2025, with order intake amounting to €70.0 million (previous year: €84.0 million). This meant that order momentum was once again lower than in the two previous quarters. In the Advanced Backend Solutions segment, which contributed €62.4 million (previous year: €67.7 million) to order intake in the third quarter, Bonding solutions achieved their highest order volume so far this year. Order intake for our Coating solutions also remained strong, but did not quite match the level of the second quarter. On the other hand, demand for Imaging solutions improved between July and September 2025, especially for our UV projection scanner. In the Photomask Solutions segment, order intake was below the level of the previous quarters and amounted to only €7.6 million (previous year: €16.3 million). SUSS thus achieved total order intake of €236.8 million in the first nine months (previous year: €276.2 million). Further details on the segments can be found in the section "Development in the Segments".

At €118.0 million, sales in the third quarter of 2025 were up 15.1% on the same quarter of the previous year (€102.5 million) and in line with our own expectations. Based on the slower order momentum in the year to date, we anticipated lower sales in the second half of 2025 than in the first half of the year and therefore began to adjust our flexible production capacities in the third quarter, primarily by reducing the number of temporary workers. In the reporting period from January to September 2025, total sales rose by 30.2% to €384.4 million (previous year: €295.3 million). Both segments contributed to this increase in the year to date, with growth rates of 25.9% in the Advanced Backend Solutions segment and 40.5% in the Photomask Solutions segment.

As a result of the continued high level of customer project fulfilment, the order book decreased by 35.9% to €276.1 million as of September 30, 2025 (previous year: €430.8 million). Meanwhile, tool orders scheduled for delivery in 2026 have continued to increase to approximately €140 million at the end of September 2025, excluding the service and spare parts business.

Gross profit increased by 18.1% to €137.9 million (previous year: €116.8 million) due to the higher sales volume in the first nine months. This resulted in a gross profit margin of 35.9% (previous year: 39.6%) in the first nine months of the financial year 2025. In the third quarter, the gross profit margin reached 33.1% (previous year: 39.0%), the lowest level in the year to date. The main reasons for the significant decline were additional expenses for rework during assembly and a temporary increase in customer ramp-up support efforts for already installed tools, an unfavorable product and customer mix and lower total output compared to previous quarters. These factors led to lower contributions to fixed cost coverage. In addition, there were expenses related to the new production site in Zhubei (Taiwan).

Sales expenses rose by 13.7% to €20.8 million in the first three quarters of 2025 (previous year: €18.3 million), which was less dynamic than sales. Research and development expenses increased to €34.2 million (previous year: €27.9 million) due to the hiring of new employees and intensive work on important development projects. The R&D ratio, i.e., the ratio of research and development expenditure to sales, fell by 0.5 percentage points to 8.9% due to the significantly higher sales level.

Our administrative expenses amounted to €31.7 million between January and September 2025 (previous year: €22.8 million). This disproportionate increase is mainly attributable to increased expenditure on IT and digitalization projects, including with the migration of the ERP system that has been initiated, targeted recruitment of key administrative staff, which took place mainly in 2024 but is only having a full impact on the cost structure this year, and increased expenses in connection with the modernization of existing buildings. Accordingly, the administrative expense ratio rose to 8.2% (previous year: 7.7%). In total, sales, administrative, and research and development expenses increased by 25.8% to €86.8 million (previous year: €69.0 million) in the year to date, which is slightly below the rate of sales growth. In the third quarter, strict cost management limited expenses to €27.3 million, which was significantly below the €32.5 million in the second quarter and only slightly above the €27.0 million in the first quarter of 2025.

The balance of other operating income and expenses was positive in the reporting period, amounting to €3.2 million (previous year: €-0.4 million). This was mainly due to a positive valuation effect from foreign currency receivables and liabilities.

EBIT rose to €54.3 million in the first three quarters of the financial year 2025 (previous year: €47.4 million), mainly due to the increase in gross profit. The EBIT margin fell to 14.1% (previous year: 16.1%) in the first nine months of the financial year due to one-time effects in the first half of the year – mainly start-up costs for the higher production volume of UV projection scanners and write-downs in connection with the discontinuation of a technology project – as well as the unsatisfactory gross profit margin already described. Between July and September, the EBIT margin was 10.5% (previous year: 16.9%).

The financial result for the first three quarters amounted to €0.7 million (previous year: €2.1 million), down 66.7% on the previous year's figure, which benefited from significantly higher interest income due to the elevated interest rates in the first nine months of 2024. Earnings from continuing operations after taxes amounted to €39.8 million in the first nine months (previous year: €35.4 million), an improvement of €4.4 million or 12.4% in the reporting period. In connection with the sale of the MicroOptics business to Focuslight Technologies (HK) Investment Management Co. Ltd., earnings from discontinued operations after taxes amounted to €-3.4 million in the second quarter of the reporting period (previous year: €58.3 million), as reported in the half-yearly financial report. Overall, net income for the reporting period amounted to €36.4 million, compared to €93.8 million in the same period of the previous year.

Business development in the key regions

The APAC (Asia and Pacific), North America, and EMEA (Europe, Middle East, and Africa) regions are the most important global regions for the business of SUSS. In the first nine months of 2025, the APAC region accounted for by far the largest share of order intake at 76.1% (previous year: 75.1%).

Sales in the APAC region rose by 26.9% to €324.9 million in the first nine months of the financial year 2025 (previous year: €256.0 million), contributing 84.5% (previous year: 86.3%) to consolidated sales. Taiwan and China accounted for the largest share of both order intake and sales in the year to date. In the North America region, sales in the first three quarters amounted to €30.4 million, compared with €19.3 million in the previous year. Sales in the EMEA region rose from €21.3 million in the previous year to €29.0 million.

Development in the segments

Segment Advanced Backend Solutions

The Advanced Backend Solutions segment combines the development, manufacture, and sale of Imaging Systems (mask aligners and UV projection scanners), Coating Systems (coaters/developers and systems for inkjet coating processes), and Bonding Systems (temporary and permanent bonders) product lines. Production of these product lines is based in Germany at the sites in Garching near Munich and Sternenfels and in Taiwan. The main target market for this segment is the advanced backend of the semiconductor industry.

Key figures Segment Advanced Backend Solutions

in € million	Q3 2025	Q3 2024	9M 2025	9M 2024
Order intake	62.4	67.7	182.5	198.1
Order book	-	-	187.3	274.2
Sales	92.8	72.8	262.9	208.8
Gross profit	30.5	29.3	90.1	86.8
Gross profit margin	32.9%	40.2%	34.3%	41.6%
EBIT	8.6	12.0	26.6	33.3
EBIT margin	9.3%	16.5%	10.1%	15.9%

In the first nine months of 2025, we generated order intake of €182.5 million in the Advanced Backend Solutions segment. Compared with the prior-year figure of €198.1 million, this represents a decline of 7.9%. The encouragingly high demand for Coating solutions, particularly for applications in the advanced packaging sector, continued in the third quarter and was a key driver of segment order intake in the year to date. However, this was not enough to fully offset the decline in order intake for bonders, even though demand for temporary bonders and debonders was slightly higher in the third quarter of 2025 than in the two previous quarters. Order intake for imaging solutions increased slightly between January and September 2025 compared with the previous year, thanks to followup orders for our UV projection scanners, which are used in the leading packaging process for AI chip modules.

The order book for the Advanced Backend Solutions segment amounted to €187.3 million as of September 30, 2025, down from €274.2 million as of September 30, 2024, due to the accelerated fulfillment of customer orders and simultaneously subdued demand.

Sales in the Advanced Backend Solutions segment grew significantly in the first three quarters of 2025, rising by €54.1 million or 25.9% to €262.9 million (previous year: €208.8 million). All three product lines contributed to the increase in sales. In the Bonding Systems, the continued fulfilment of AI-related orders for temporary bonding solutions led to slight growth. By contrast, Coating and Imaging Systems recorded significantly higher growth rates of over 50% each, contributing to segment sales.

The gross profit margin of the Advanced Backend Solutions segment fell to 34.3% in the first nine months of 2025 (previous year: 41.6%). The decline was mainly due to additional expenses for rework during assembly and a temporary increase in customer ramp-up support efforts for already installed tools, an unfavorable change in the product and customer mix, start-up costs for the production of UV projection scanners, and one-time effects from write-downs on inventories in connection with a discontinued technology project. Due to expenses for the new production site in Zhubei (Taiwan) and a lower total output compared to previous quarters, which led to lower contributions to fixed cost coverage, the trend worsened in the third quarter with a gross profit margin of 32.9% (previous year: 40.2%).

EBIT in the segment amounted to €26.6 million after three quarters (previous year: €33.3 million). The decline was primarily attributable to increased research and development expenses, volume-related increases in sales costs, and the rise in administrative expenses discussed above. The only slight increase in gross profit was not enough to compensate for this development. The EBIT margin in the Advanced Backend Solutions segment was therefore 10.1% (previous year: 15.9%).

Segment Photomask Solutions

The Photomask Solutions segment comprises the development, manufacture, and sale of solutions specializing in the cleaning and processing of photomasks. primarily in the front end of semiconductor manufacturing.

Key figures Segment Photomask Solutions

in € million	Q3 2025	Q3 2024	9M 2025	9M 2024
Order intake	7.6	16.3	54.3	78.1
Order book	-	-	88.9	156.7
Sales	25.2	29.7	121.5	86.5
Gross profit	8.0	11.0	46.7	30.6
Gross profit margin	31.7%	37.0%	38.4%	35.4%
EBIT	4.3	6.9	32.0	17.9
EBIT margin	17.1%	23.2%	26.3%	20.7%

Order intake in the Photomask Solutions segment declined in the first three quarters of 2025, falling from €78.1 million in the same period of the previous year to €54.3 million as of September 30, 2025. The main reason for the decline in order intake was the expected significant reduction in order volumes from our customers in China compared with previous years. Demand from major global chip manufacturers only partially offset this decline. In the third quarter of 2025, order intake reached a low for the year to date at €7.6 million.

The order book decreased to €88.9 million as of September 30, 2025 (previous year: €156.7 million). The book-to-bill ratio, i.e., the ratio of orders to sales, was very low at 0.45 in the year to date.

Sales in the Photomask Solutions segment increased by €35.0 million or 40.5% to €121.5 million in the first nine months of 2025 (previous year: €86.5 million). The €4.5 million decline in sales in the third quarter to €25.2 million (previous year: €29.7 million) is not representative of the segment's performance. Due to the high unit price and the comparatively low volume of tools, delays in delivery or acceptance can lead to sales being recognized only in the following period, thus significantly influencing the short-term development of sales and profitability.

The gross profit margin improved significantly in the first three quarters of 2025, from 35.4% to 38.4%. This development was mainly due to higher sales volume and a favorable product and customer mix in the first half of the year. In the third quarter of 2025, the gross profit margin was significantly below the level of previous quarters at 31.7% due to a change in the customer mix and lower sales volume.

Segment EBIT significantly increased from €17.9 million to €32.0 million in the first three quarters of 2025, corresponding to an increase of 78.8%, due to the rise in gross profit from sales. The EBIT margin improved accordingly from 20.7% to 26.3%.

Central Group Functions

Central Group Functions mainly comprise expenses and income from central Group functions that are not attributable to the operating segments. In the first nine months of 2025, Central Group Functions generated EBIT of €-7.7 million (previous year: €55.2 million). EBIT included one-time expenses of €3.4 million for discontinued operations. In the previous year, EBIT included extraordinary income of €58.1 million from the sale of the MicroOptics business.

Assets and financial position

Assets

Total assets rose by 4.4% to €522.9 million in the reporting period (December 31, 2024: €500.9 million). In terms of non-current assets, property, plant, and equipment increased in particular as a result of the capitalization of the right of use for the new Zhubei (Taiwan) site and the furnishing of the building. As of September 30, 2025, property, plant, and equipment amounted to €85.5 million (December 31, 2024: €33.8 million). On the liabilities side, financial liabilities from leasing obligations rose to €40.9 million (December 31, 2024: €5.7 million) because of the recognition of the lease agreement in the balance sheet.

Equity increased by €24.5 million to €304.2 million due to the positive overall result for the period. The equity ratio rose to 58.2% as of September 30, 2025 (December 31, 2024: 55.8%).

Cash and cash equivalents amounted to €94.4 million as of September 30, 2025 (December 31, 2024: €136.2 million). This includes €0.5 million that is currently not freely available due to payments made to sanctioned business partners in accordance with the US sanctions list.

Cash flow statement

Total cash flow from operating activities between January and September 2025 amounted to €–10.4 million (comparable period: €+30.3 million). Contractual assets increased in the reporting period. The change amounted to €–12.8 million in the first nine months (comparable period: €+4.7 million) and thus had a negative impact on cash flow development. Contractual liabilities, which consist of advance payments from customers, decreased, particularly due to a lower order volume. This had a negative impact of €-30.4 million on operating cash flow in the reporting period (comparable period: €+11.7 million). In the third quarter, cash flow from operating activities amounted to €+5.9 million.

Cash flow from investing activities amounted to €–21.2 million, which was primarily attributable to the establishment of the new site in Zhubei (Taiwan) (comparable period: €+73.9 million). It should be noted that cash flow from investing activities includes a one-time effect of €-3.4 million from discontinued operations, as a payment was made in connection with the sale of the MicroOptics business. In the comparable prior-year period, cash flow from investing activities included a positive amount of €+69.5 million from the divestment. Free cash flow after the first nine months of the financial year 2025 was €–31.5 million (previous year: €+94.3 million).

Post-balance sheet date events

Due to unsatisfactory business performance in the third quarter of 2025 and following a thorough analysis of the expected performance for the fourth quarter of 2025, the company adjusted its forecast for the full year on October 27, 2025.

Risks and opportunities

The analysis and assessment of the Group's opportunities and risks is the subject of ongoing consideration by the Management Board and the operational management team. Based on opportunityoriented yet risk-conscious management, we strive to achieve a balance between risk avoidance, risk reduction, and controlled risk acceptance. Awareness of risks should not impair our ability to recognize opportunities and use them in the interests of our shareholders for the positive development of the company. For a complete description of our approach to identifying, assessing, and managing the risks and opportunities of the SUSS Group, please refer to the explanations in our combined management report for the year 2024.

The risks to the business development of SUSS have changed since the assessment in the half-year report. The risk arising from the revaluation of inventories has increased. Since SUSS has committed to purchasing certain minimum quantities in long-term supply contracts, the delivery quantities for individual components cannot be adjusted completely flexibly to lower demand. Accordingly, inventories are rising, and with them the risk of impairment. In addition, due to the current order situation, there is an increased risk that our production capacities will not be flexible enough to adjust to a further decline in total output. Costs of underutilization and other countermeasures that may be necessary to further adjust capacity could place additional strain on earnings. The opportunities arising from market developments and corporate strategy, operational opportunities, and employee-specific opportunities as described in the opportunity report in the management report in the 2024 Annual Report remain unchanged.

Outlook

As expected, sales slowed in the third quarter. Between July and September 2025, sales amounted to €118.0 million, which was below the level of the two previous quarters. Due to the continuing unsatisfactory order intake, we began reducing our flexible production capacities in the third quarter of 2025 by significantly reducing the number of temporary workers in production. Overall, sales grew by 30.2% to €384.4 million in the first three quarters of 2025, representing a very positive development. Accordingly, we remain confident that we will achieve our annual sales targets.

The gross profit margin achieved in the first nine months was 35.9%, which was below the forecast range communicated in July 2025. In particular, start-up costs for the increased production volume of the UV projection scanner, write-downs on inventories of discontinued technology projects, additional expenses for rework during assembly and a temporary increase in customer ramp-up support efforts for already installed tools, and lower fixed cost coverage due to lower total output compared to previous quarters weighed on the gross profit margin. An unfavorable product and customer mix and expenses related to the new production site in Zhubei (Taiwan) also had a negative impact on the gross profit margin. At 14.1%, the EBIT

margin was in the middle of the target range valid since July 28, 2025.

As margin pressure is expected to continue in the further course of the 2025 financial year, we revised our guidance for the gross profit margin and EBIT margin downward on October 27, 2025. The postponement of customer projects with favorable margin profiles and the pull-in of projects with less attractive margins will weigh on the fourth quarter. The effect of lower contributions to fixed cost coverage as a result of declining total output will also continue.

The reluctance of our customers to invest in additional capacity, which was anticipated by numerous market participants – including us – has continued in recent months. Order intake of €70.0 million in the third quarter of 2025 marked an annual low. Ongoing uncertainties in the customs and trade policy environment and the tendency to place orders for new projects as late as possible in view of recent capacity expansions continued to have an impact. At the same time, several leading global semiconductor manufacturers announced massive investments for the coming years, particularly in connection with additional capacity for AI applications. Key customers also made progress in the development and qualification of new products. We do not expect any significant changes in the overall economic environment for the rest of the year, but we do anticipate a significant upturn in order intake in the fourth quarter of 2025 to a level well above that of the third quarter.

The order book as of September 30, 2025, amounted to €276.1 million (previous year: €430.8 million).

Performance indicator	Forecast 2025	Result 2024
Sales	€ 470 – 510 million	€ 446.1 million
Gross profit margin	35 – 37 %	40.0 %
EBIT margin	11 – 13 %	16.8 %

For our revised outlook, this means that, based on our current assessment, we continue to expect to achieve our sales target for 2025 in a range of €470 million to €510 million. We expect the gross profit margin to be in a range of 35 to 37% and the EBIT margin in a range of 11 to 13%.

Strict cost management in the remainder of the financial year 2025 should ensure that the adjusted targets for the gross profit margin and EBIT margin will be achieved. At the same time, we are utilizing the flexibility in our production network and gradually reducing the number of temporary workers in order to adjust production capacities to the lower order volume. We are also currently reviewing measures aimed at achieving a sustainable improvement in cost structures. In order to lay the foundation for our future growth, we are sticking to our plans in the area of research and development as well as our strategic structural projects.

Forward-looking statements

This Interim Statement contains information and forecasts relating to future developments of the SUSS Group and its companies. The forecasts represent estimates that we have made based on all the information available to us at the present time. If the assumptions underlying the forecasts do not materialize or if unforeseen events occur that affect earnings, the actual results may differ from those currently expected. We assume no obligation and do not intend to update the forward-looking statements or to correct them if developments other than those expected occur.

Garching, Germany, November 5, 2025

Signed

Burkhardt Frick

Chief Executive Officer (CEO)

Dr. Cornelia Ballwießer Chief Financial Officer (CFO)

Dr. Thomas Rohe

Chief Operations Officer (COO)

Financial Report (unaudited)

Consolidated statement of income (IFRS)

for the period from January 1 to September 30, 2025

in € thousand	07/01/2025 -09/30/2025	07/01/2024 -09/30/2024	01/01/2025 -09/30/2025	01/01/2024 -09/30/2024
Sales	117,962	102,481	384,396	295,257
Cost of sales	-79,003	-62,453	-246,454	-178,410
Gross profit	38,959	40,028	137,942	116,847
Selling costs	-6,296	-5,959	-20,841	-18,293
Research and development costs	-10,867	-9,352	-34,228	-27,938
Administration costs	-10,135	-7,801	-31,724	-22,774
Other operating income	1,780	1,358	7,395	3,503
Other operating expenses	-1,033	-951	-4,241	-3,942
Net income from operations (EBIT)	12,408	17,323	54,303	47,403
Financial income	315	937	1,393	2,446
Financial expenses	-509	-124	-700	-330
Financial result	-194	813	693	2,116
Profit before taxes (continuing operations)	12,214	18,136	54,996	49,519
Income taxes	-3,030	-5,219	-15,170	-14,081
Profit continuing operations (after taxes)	9,184	12,917	39,826	35,438
Profit discontinued operations (after taxes)	-1	0	-3,408	58,318

in € thousand	07/01/2025 -09/30/2025	07/01/2024 -09/30/2024	01/01/2025 -09/30/2025	01/01/2024 -09/30/2024
Net profit	9,183	12,917	36,418	93,756
Thereof shareholders of SUSS MicroTec SE	9,183	12,917	36,418	93,756
Thereof non-controlling interests	0	0	0	0
Earnings per share continuing operations (basic) in €	0.48	0.68	2.08	1.85
Earnings per share continuing operations (diluted) in €	0.48	0.68	2.08	1.85

Statement of comprehensive income (IFRS)

for the period from January 1, 2025, to September 30, 2025

in € thousand	01/01/2025 - 09/30/2025	01/01/2024 - 09/30/2024
Net profit	36,418	93,756
Items that are not reclassified to profit and loss in future periods
Actuarial gains / losses from defined benefit pension plans (from the disposal of losses from the sale of subsidiaries)	8	1,652
Tax effects (from the disposal of losses from the sale of subsidiaries)	0	-206
Other income after tax for items that are not reclassified as an expense or income	8	1,446
Items that are reclassified in later periods
Foreign currency adjustment
gains and losses arising in the current period	-6,188	-115
less transfers to the income statement	0	-4,518
Foreign currency adjustment total	-6,188	-4,633
Other income after tax for items that are reclassified as an expense or income in future periods	-6,188	-4,633
Other comprehensive income (after tax)	-6,180	-3,187
Total other comprehensive income	30,238	90,569
thereof shareholders of SUSS	30,238	90,569
thereof non-controlling interests	0	0

Consolidated balance sheet (IFRS)

as of September 30, 2025

Assets
in € thousand	09/30/2025	12/31/2024
Non-current assets
Intangible assets	4,017	4,616
Goodwill	18,373	18,631
Tangible assets	85,468	33,815
Other assets	1,076	845
Deferred tax assets	663	697
Non-current assets	109,597	58,604
Current Assets
Inventories	201,913	213,971
Trade receivables	24,984	14,861
Contract assets	71,451	58,890
Other financial assets	497	1,204
Current tax assets	531	67
Cash and cash equivalents	94,439	136,239
Other assets	19,530	17,037
Current assets	413,345	442,269
Total assets	522,942	500,873

Consolidated balance sheet (IFRS)

as of September 30, 2025

Liabilities & shareholders' equity
in € thousand	09/30/2025	12/31/2024
Equity
Subscribed capital	19,116	19,116
Reserves	293,095	262,411
Accumulated other comprehensive income	-7,962	-1,781
Equity	304,249	279,746
Total equity attributable to shareholders of SUSS MicroTec SE	304,249	279,746
Non-current liabilites
Pension plans and similar commitments	1,575	1,800
Provisions	2,862	3,911
Financial debt	3,125	4,063
Financial debt from lease obligations	40,941	5,708
Other financial liabilities	2,193	1,467
Other liabilities	688	820
Deferred tax liabilities	25,861	20,847
Non-current liabilities	77,245	38,616

09/30/2025	12/31/2024
4,451	4,225
9,582	20,578
1,259	1,266
5,202	2,258
17,127	18,078
26,166	31,546
68,811	99,443
8,850	5,117
141,588	182,511
522,942	500,873

Consolidated statement of changes in equity (IFRS)

as of September 30, 2025

				Accumulated other comprehensive income
in € thousand	Subscribed capital	Additional paid-in capital	Earnings reserve	Remeasurement of defined benefit plans	Deferred taxes	Foreign currency adjustments	Total equity attributable to shareholders of SUSS MicroTec SE
As of January 1, 2024	19,116	55,822	101,502	-3,278	638	2,817	176,617
Net income			93,756				93,756
Other income*				1,652	-206	-4,633	-3,187
Total comprehensive income			93,756	1,652	-206	-4,633	90,569
Dividends paid			-3,823				-3,823
Effect from divestment of a subsidiary			-1,432				-1,432
As of September 30, 2024	19,116	55,822	190,003	-1,626	432	-1,816	261,931
As of January 1, 2025	19,116	55,822	206,590	-2,065	548	-265	279,746
Net income			36,418				36,418
Other income				8	-	-6,188	-6,180
Total comprehensive income			36,418	8	-	-6,188	30,238
Dividends paid			-5,735				-5,735
As of September 30, 2025	19,116	55,822	237,273	-2,057	548 0	-6,453	304,249

^* Includes a reclassification effect of € 1.432 thousand from the sale of a subsidiary.

Consolidated statement of cash flow (IFRS)

for the period from January 1, 2025, to September 30, 2025

In € thousand	01/01/2025 - 09/30/2025	01/01/2024 - 09/30/2024
Net profit	36,418	93,756
Adjustments to reconcile net income / (loss) to operating cash flows
Income / (loss) from discontinued operations (net of taxes)	3,408	-58,318
Amortization of intangible assets	1,318	1,191
Depreciation of tangible assets	5,860	4,499
Profit / loss on disposal of intangible and tangible assets	59	1
Change of reserves on inventories	3,255	1,153
Non-cash interest expenses from increase of convertible debt	-9	-127
Other non-cash effective income and expenses	-3,415	740
Change in inventories	7,808	-51,725
Change in contract assets	-12,801	4,678
Change in trade receivables	-10,549	3,835
Change in other assets	-2,017	-7,495
Change in pension provisions	-203	-170
Change in trade payables*	-5,233	9,804
Change in contract liabilities	-30,431	11,733

In € thousand	01/01/2025 - 09/30/2025	01/01/2024 - 09/30/2024
Change in other liabilities and other provisions	2,527	5,780
Change in tax assets and tax liabilities	-6,385	10,082
Cash flow from operating activities – continuing operations*	-10,390	29,417
Cash flow from operating activities – discontinued operations*	0	929
Cash flow from operating activities – total*	-10,390	30,346
Disbursements for other tangible assets	-17,050	-5,079
Disbursements for intangible assets	-725	-444
Cash outflows due to investments within short-term commercial paper	0	0
Cash income due to investments within short-term commercial paper	0	9,895
Cash flow from investing activities – continuing operations	-17,775	4,372
Cash flow from investing activities – discontinued operations*	-3,379	69,522
Cash flow from investing activities – total*	-21,154	73,894

^* Previous year's figures have been reclassified.

Continued on the next page ▼

Consolidated statement of cash flow (IFRS)

▼ Continuation

in € thousand	01/01/2025 - 09/30/2025	01/01/2024 - 09/30/2024
Repayment of bank loans	-938	-938
Repayment of rental and lease liabilities	-2,506	-1,952
Change in other financial debt	-7	14
Dividends paid	-5,735	-3,823
Cash flow from financing activities - continuing operations	-9,186	-6,699
Cash flow from financing activities - discontinued operations	0	0
Cash flow from financing activities	-9,186	-6,699
Adjustments to funds caused by exchange-rate fluctuations	-1,070	-153
Change in cash and cash equivalents	-41,800	97,388
Funds at the beginning of the year	136,239	38,756
Funds at end of the period	94,439	136,144
(thereof cash and cash equivalents from discontinued operations)*	0	642
(of which cash and cash equivalents not at disposal)	489	0
Cash flow from operating activities (continuing operations) including:
Interest paid during the period	141	173
Interest received during period	1,281	2,190
Taxes paid during the period	16,617	3,834

^* Previous year's figures have been reclassified

Further details on the financial report

Segment reporting (IFRS)

Segment reporting by business segment
	Advanced Backend Solutions		Photomask Solutions		Total of segments		MicroOptics*		Central Group Functions**		Total
in € thousand	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024
External sales	262,925	208,803	121,471	86,450	384,396	295,253	-	1,329	-	4	384,396	296,586
Internal Sales	-	-	-	-	-	-	-	-	-	-	-	-
Total sales	262,925	208,803	121,471	86,450	384,396	295,253	-	1,329	-	4	384,396	296,586
Cost of sales	-172,831	-121,984	-74,758	-55,803	-247,589	-177,787		-1,384	+1,135	-623	-246,454	-179,794
Gross profit	90,094	86,819	46,713	30,647	136,807	117,466	-	-55	1,135	-619	137,942	116,792
Gross profit margin	34.3%	41.6%	38.5%	35.5%	35.6%	39.8%		-4.1%			35.9%	39.4%
Other segment expenses / income (net)	-63,479	-53,505	-14,676	-12,744	-78,155	-66,249	-	-270	-8,864	55,811	-87,019	-10,708
thereof intersegment cost allocation (net)	-11,072	-10,382	-4,478	-3,352	-15,550	-13,734	-	-	15,550	13,734	-	-
thereof central services of SUSS MicroTec SE	-11,072	-10,382	-4,478	-3,352	-15,550	-13,734	-	-	15,550	13,734	-	-
Result per segment (EBIT)	26,615	33,314	32,037	17,903	58,652	51,217	-	-325	-7,729	55,192	50,923	106,084
EBIT margin	10.1%	16.0%	26.4%	20.7%	15.3%	17.3%		-24.5%			13.2%	35.8%
Earnings before taxes	26,570	33,277	32,035	17,899	58,605	51,176	-	-325	-7,044	57,349	51,561	108,200
Significant non-cash items	-276	-4,791	-1,452	2,440	-1,728	-2,351	-	-	27	375	-1,701	-1,976

^* Discontinued operations

^** No operating segment in accordance with IFRS 8

Segment reporting (IFRS)

Continuation ▼

Segment reporting by business segment
	Advanced Backend Solutions			Photomask Solutions	Total of segments			MicroOptics*		Central Group Functions**	Total
in € thousand	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024	9M / 2025	9M / 2024
Segment assets	302,258	229,971	86,478	70,031	388,736	300,002	-	-	17,470	17,652	406,206	317,654
thereof goodwill	18,373	18,472			18,373	18,472					18,373	18,472
Unallocated assets											116,736	156,601
Total assets											522,942	474,255
Segment liabilities	-78,545	-40,655	-33,526	-13,466	-112,071	-54,121	-	-	-4,301	-4,441	-116,372	-58,562
Unallocated liabilities											-102,321	-134,553
Total liabilities											-218,693	-193,115
Depreciation and amortization	4,745	3,615	989	653	5,734	4,268	-	-	1,444	1,422	7,178	5,690
thereof scheduled	4,745	3,615	989	653	5,734	4,268	-	-	1,444	1,422	7,178	5,690
thereof impairment loss	-	-	-	-	-	-	-	-	-		- -	-
Capital expenditure	13,078	3,744	3,340	1,288	16,418	5,032	-	-	1,357	491	17,775	5,523
Employees as of September 30	1,193	1,108	272	257	1,465	1,365	-	-	63	49	1,528	1,414

^* Discontinued operations

^** No operating segment in accordance with IFRS 8

Segment reporting (IFRS)

Segment information by region
	Sales			Capital expenditure	Assets (without Goodwill)
in € thousand	9M / 2025	9M / 2024*	9M / 2025	9M / 2024*	9M / 2025	9M / 2024*
EMEA	29,016	21,298	6,907	4,359	295,966	275,762
North America	30,436	19,280	47	3	4,793	4,560
Asia and Pacific	324,944	256,008	10,821	1,161	93,191	24,198
Consolidation effects					-6,117	-5,338
Total	384,396	296,586	17,775	5,523	387,833	299,182

^* Including discontinued operations.

Earnings per share

		/2025 0/2025	01/01/2024 - 09/30/2024
in € thousand	Total amount Earnings per share in € (basic)		Total amount	Earnings per share in € (basic)
Earnings after taxes (continuing operations) of which shareholders of SUSS MicroTec SE	39,286	2.08	35,438	1.85
Earnings after taxes (discontinued operations) of which shareholders of SUSS MicroTec SE	-3,408	-0.18	58,318	3.05
Net profit of which shareholders of SUSS MicroTec SE	35,878	1.91	93,756	4.90
Weighted average number of outstanding shares	19,115,538		19,115,538

There were no dilution effects in the reporting period presented.

Note

The same accounting policies have been applied to the consolidated statement of income, statement of comprehensive income, consolidated balance sheet, consolidated statement of changes in equity, consolidated cash flow statement, segment reporting, and earnings per share as in the last published Half-yearly financial statements as of June 30, 2025.

Due to rounding, it is possible that individual figures in this interim report and in other reports may not add up exactly and that percentages shown may not exactly reflect the absolute values to which they refer.

All figures in this interim report are unaudited.

Financial Calendar 2025/2026

November 6, 2025
November 17, 2025
March 30, 2026
May 7, 2026
June 3, 2026
August 6, 2026
November 5, 2026

Contact

SUSS MicroTec SE Schleissheimer Straße 90 85748 Garching, Germany

Email: info@suss.com

Investor Relations Phone: +49 89 32007-151 / -161 Email: ir@suss.com

Forward-looking statements: This Interim Statement includes forward-looking statements. Forward-looking statements do not present historical facts but include statements about expectations and the views of the management of SUSS MicroTec SE. These statements are based on current plans, estimates, and forecasts of the Company's management. Investors should not place undue reliance on these statements. Forward-looking statements are to be understood in the context of the time at which they were made. The Company does not assume any obligation to update the forward-looking statements included in this report as a result of new information or future events. The Company's obligation to comply with its statutory responsibilities regarding information and reporting remains unaffected. Forwardlooking statements always involve risks and uncertainties. A large number of factors that are described in this report could cause actual events to deviate substantially from the forward-looking statements included in this report.

suss.com